A prospective study on tt virus infection in transfusion-dependent patients with β-thalassemia

Blood

Volumn 93, Issue 5, 1999, Pages 1502-1505

  Prati, Daniele ^b   Lin, Yu Huei ^b   De Mattei, Claudia ^b   Liu, Jen Kuei ^b   Farma, Elena ^b   Ramaswamy, Latha ^b   Zanella, Alberto ^b   Lee, Helen ^b   Rebulla, Paolo ^b   Allain, Jean Pierre ^b   Sirchia, Girolamo ^b   Chen, Benjamin ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CHILD; CONTROLLED STUDY; DNA VIRUS; FEMALE; HEPATITIS VIRUS NON A NON B; HUMAN; INFANT; ITALY; MAJOR CLINICAL STUDY; MALE; NEWBORN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TORQUE TENO VIRUS; VIREMIA; VIRUS INFECTION;

EID: 0033106284     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.5.1502.405a37_1502_1505     Document Type: Article

References (27)

1. Aach RD, Stevens CE, Hollinger FB: Hepatitis C virus infection in post-transfusion hepatitis - An analysis with first- and second-generation assays. N Engl J Med 325:1325, 1991
2. Donahue JG, Muñoz A, Ness PM, Brown DE, Yawn DH, McAllister HA, Reitz BA, Nelson KE: The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 327:369, 1992
3. Nelson KE, Donahue JG, Stambolis V: Post-transfusion hepatitis C virus infection (letter). N Engl J Med 327:1601, 1992
4. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ, for the Retrovirus Epidemiology Donor Study: The risk of transfusion-transmitted viral infections. N Engl J Med 334:1685, 1996
5. Blajchman MA, Bull SB, Feinman SV: Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests. Canadian Post-Transfusion Hepatitis Prevention Study Group. Lancet 345:21, 1995
6. Prati D, Zanella A, Farma E, De Mattei C, Bosoni P, Zappa M, Picone A, Mozzi F, Rebulla P, Cappellini MD, Allain JP, Sirchia G, for the Cooleycare cooperative group: A multicenter prospective study on the risk of acquiring liver disease in anti-HCV negative patients affected from homozygous β-thalassemia. Blood 92:3460, 1998
7. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, Desai SM, Mushahwar IK: Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1:564, 1995
8. Linnen J, Wages J Jr, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, Koonin E, Gallagher M, Alter M, Hadziyannis S, Karayiannis P, Fung K, Nakatsuji Y, Shih JW, Young L, Piatak M Jr, Hoover C, Fernandez J, Chen S, Zou JC, Morris T, Hyams KC, Ismay S, Lifson JD, Hess G, Foung SKH, Thomas H, Bradley D, Margolis H, Kim JP: Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent. Science 271:505, 1996
9. Alter HJ, Nakatsuji Y, Melpolder J, Wages J, Wesley R, Shih JWK, Kim JP: The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 336:747, 1997
10. Alter HJ: The cloning and clinical implications of HGV and HGBV-C. N Engl J Med 334:1536, 1996
11. Wang JT, Tsai FC, Lee CZ, Chen PJ, Sheu JC, Wang TH, Chen DS: A prospective study of transfusion-transmitted GB virus C infection: Similar frequency but different clinical presentation compared with hepatitis C virus. Blood 88:1881, 1996
12. Prati D, Zanella A, Bosoni P, Rebulla P, Farma E, De Mattei C, Capelli C, Mozzi F, Gallisai D, Magnano C, Melevendi C, Sirchia G, for the Cooleycare cooperative group: The incidence and natural course of transfusion-associated hepatitis G virus infection in a cohort of thalassemic patients. Blood 91:774, 1998
13. Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M: A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 241:92, 1997
14. Okamoto H, Nishizawa T, Kato N, Ukita M, Ikeda H, Iizuka H, Miyakawa Y, Mayumi M: Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology. Hepatol Res 10:1, 1998
15. Simmonds P, Davidson F, Lycett C, Prescott LE, MacDonald DM, Ellender J: Detection of a novel DNA virus (TTV) in blood donors and blood products. Lancet 352:191, 1998
16. Naoumov NV, Petrova EP, Thomas MG, Williams R: Presence of a newly described human DNA virus (TTV) in patients with liver disease. Lancet 352:197, 1998
17. Rebulla P, Modell B: Transfusion requirements and effects in patients with thalassaemia major. Lancet 337:277, 1991
18. Prati D, Capelli C, Rebulla P, Mozzi F, Bosoni P, De Mattei C, Sirchia G, for the Cooleycare cooperative group: The current risk of retroviral infections transmitted by transfusion in patients who have undergone multiple transfusions. Arch Intern Med 158:1566, 1998
19. Rebulla P, Mozzi F, Contino G, Locatelli E, Sirchia G: Antibody to hepatitis C virus in 1,305 Italian multiply transfused thalassaemics: Comparison of first and second generation tests. Transfus Med 2:69, 1992
20. Mozzi F, Rebulla P, Lillo F, Varnier OE, Biadati C, Calcagno L, Melotti S, Sirchia G, and the Cooleycare cooperative group: HIV and HTLV infections in 1305 transfusion-dependent thalassemics in Italy. AIDS 6:505, 1992
21. Prati D, Capelli C, Zanella A, Mozzi F, Bosoni P, Pappalettera M, Zanuso F, Vianello L, Locatelli E, De Fazio C, Ronchi G, Del Ninno E, Colombo M, Sirchia G: Influence of different hepatitis C virus genotypes on the course of asymptomatic hepatitis C virus infection. Gastroenterology 110:178, 1996
22. Prati D, Capelli C, Zanella A, Bosoni P, De Mattei C, Mozzi F, Donato MF, Colombo M, Milani S, Sirchia G: Asymptomatic hepatitis G virus infection in blood donors. Transfusion 37:1200, 1997
23. De Filippi F, Colombo M, Rumi MG, Tradati F, Prati D, Zanella A, Mannucci PM: High rates of hepatitis G virus infection in multitransfused patients with hemophilia. Blood 90:4634, 1997
24. Okamoto H, Akahane Y, Ukita M, Fukuda M, Tsuda F, Miyakawa Y, Mayumi M: Fecal excretion of a nonenveloped DNA virus (TTV) associated with posttransfusion non-A-G hepatitis. J Med Virol 56:128, 1998
25. Olivieri NF, Brittenham GM: Iron-chelating therapy and the treatment of thalassemia. Blood 89:739, 1997
26. Zanella A, Rossi F, Cesana C, Foresti A, Nador F, Binda AS, Lunghi G, Cappellini MD, Furione M, Sirchia G: Transfusion-transmitted human parvovirus B19 infection in a thalassemic patient. Transfusion 35:769, 1995
27. Lefrére JJ, Couroucé AM, Girot R, Cornu P: Human parvovirus and thalassemia. J Infect 13:45, 1986